| ID: | 195 | |
|---|---|---|
| Name: | Compound 195 | |
| Description: | Original numeration in publication: 8a | |
| Labels: | Training_set, Thiazolidine-2, 4-dione | |
| CAS: | ||
| InChi Code: | InChI=1S/C21H19N3O4S/c1-2-22-19(26)15-8-10-16(11-9-15)23-18(25)13-24-20(27)17(29-21(24)28)12-14-6-4-3-5-7-14/h3-12H,2,13H2,1H3,(H,22,26)(H,23,25)/b17-12- |
pIC50: Negative logarithm of half-maximal inhibitory concentration [-log(uM)]
| Value | Source or prediction |
|---|---|
| 6.17 |
El-Adl, K.; El-Helby, A.-G. A.; Sakr, H. a. E., I. H.; El-Hddad, S. S. A.; M I A Shoman, F. Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme. Bioorg. Chem. 2020, 102, 104059. https://doi.org/j.bioorg.2020.104059 |
| 6.99173 |
Eq1: VEGFR-2 inhibition (Data used to train model) |